Author: Li Yuxin
Publisher: Springer Publishing Company
ISSN: 0167-6806
Source: Breast Cancer Research and Treatment, Vol.128, Iss.3, 2011-08, pp. : 667-677
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Wickham C. Armitage H. Joyner M. Sarsfield P. Boyce M. Wilkins B. Jones D. Ellard S.
Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. :
MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2
Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. :
By Grillo Mary Bott Matthew Khandke Neha McGinnis John Miranda Miriam Meyyappan Muthupalaniappan Rosfjord Edward Rabindran Sridhar
Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. :